Skip to main content
logo
CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.21372
+0.00372 (1.77%)
At close: Sep 18, 2026

CytoDyn Financials Overview

Millions USD. Fiscal year is Jun - May.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Revenue
-----0.27
Revenue Growth
------
Gross Profit
-----20.63-73.28
Operating Income
-23.15-23.159.66-18.06-40.58-145.4
Net Income
-44.18-44.182.26-51.32-86.74-212.45
Earnings Per Share
-0.03-0.030.00-0.05-0.10-0.31
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Cash & Investments
11.8511.8511.93.112.544.23
Total Debt
27.2827.2827.3430.0835.5536.8
Net Cash (Debt)
-15.42-15.42-15.44-26.97-33.01-32.57
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.01-0.03-0.04-0.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Operating Cash Flow
-17.25-17.25-8.77-10.98-25.11-77.72
Capital Expenditures
------
Free Cash Flow
-17.25-17.25-8.77-10.98-25.11-77.72
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Operating Margin
------54663.16%
Pretax Margin
------79255.64%
Profit Margin
------79867.67%
FCF Margin
------29219.17%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 May '26 May '25 May '24 May '23 May '22
PE Ratio
--188.79---
Forward PE
-10.1610.1610.1610.1610.16
PS Ratio
-----867.10